How would you approach therapy for a transplant-eligible patient with peripheral T cell lymphoma NOS who experiences early relapse after CHOEP, but achieves remission to salvage therapy?   

Not an easy question, and certainly, not one with a single right answer. The body of literature comparing auto to allo in r/r PTCL-NOS while mixed can be reasonably distilled to the observation that both are appropriate, but neither is definitively better.  Therefore, there's a lot that goes i...